• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Neonatal exposure to methadone associated with worse neurobehavioural outcomes

byKathleen LauandAlex Chan
October 19, 2020
in Obstetrics, Pediatrics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Newborns exposed to methadone prenatally had worse neurobehavior scores than those who were not.

2. Infants belonging to one of four particular neurobehavioral profiles were associated with poorer cognitive and neuromotor outcomes at 24 months.

Evidence Rating Level: 2 (Good)

As the opioid crisis continues to take its toll in North America, many pregnant mothers are using opioid agonist therapy, such as methadone and buprenorphine, as safer, controlled prescription alternatives. Infants whose mothers used methadone treatment during pregnancy are known to exhibit differences in the Neonatal Intensive Care Unit Network Neurobehavioral Scale (NNNS). The long term effects on neurodevelopment of the infant is far more limited due to poorer quality or smaller studies. This study used data from the prospective, longitudinal Christchurch Methadone In Pregnancy (MIP) Study and had two aims. One was to compare neurobehaviors in infants exposed prenatally to methadone (n=86) to those who were not (n=103) and the other was to identify a specific neurobehavioral profile that was linked to worse neurodevelopmental outcomes at 2 years of age. Using NNNS summary scores, infants exposed to methadone prenatally had poorer attention, regulation, and quality of movement, increased excitability, arousability, expression of non-optimal reflexes, hypertonicity, and total signs of stress abstinence, including those of central nervous system, visual, genitourinary, and state. From this group of subjects, four unique neurobehavioral profiles were created. One profile, Profile 4, had poorer attention scores than most of the other profiles, required the most handling, had the lowest scores on self-regulation and the highest on arousal, excitability, hypertonicity, non-optimal and asymmetric reflexes, and exhibited the highest stress abstinence and poorest quality of movement. Infants of this profile had the poorest NSSS score and were more likely to be born to mothers on welfare with more pregnancies and terminations, to be male, to be born preterm and smaller at birth, to spend more than 2 weeks in a special care baby unit and more than 2 weeks in hospital postnatally, and to be more likely to need pharmacological treatment for neonatal abstinence syndrome. Children of this profile had the worst clinical outcomes at 24 months assessed by BSD-II, MDI and PDI, scales of child cognitive and neuromotor function, respectively. This study confirmed the findings of previous studies that exposure to methadone prenatally can significantly affect neurobehaviors at birth compared to unexposed infants. Furthermore, infants belonging to the certain neurobehavior profile 4 (13% of infants) had the worst outcomes of all methadone-exposed individuals at 24 months. These findings can help identify infants who may be at increased risk of worse neurodevelopment compared to others exposed to methadone prenatally.

Click to read the study in PLOSONE

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Expectant management of patent ductus arteriosus noninferior to early ibuprofen use

SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring

Lebrikizumab effective in treating moderate-to-severe atopic dermatitis

Tags: addictionsobstetricsopioidspediatrics
Previous Post

2 Minute Medicine Rewind October 19, 2020

Next Post

Extracorporeal membrane oxygenation shows benefit for patients with COVID-19 related severe acute respiratory distress syndrome.

RelatedReports

Wide international variation in survival for periviable neonates
Cardiology

Expectant management of patent ductus arteriosus noninferior to early ibuprofen use

March 30, 2023
Paternal factors associated with short interpregnancy interval
Infectious Disease

SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring

March 29, 2023
Pimecrolimus effective first-line treatment for atopic dermatitis
Chronic Disease

Lebrikizumab effective in treating moderate-to-severe atopic dermatitis

March 29, 2023
Nivolumab may be effective in platinum-resistant ovarian cancer
Obstetrics

Immediate postpartum opioid administration not associated with adverse infant outcomes

March 28, 2023
Next Post
Initial data on the viability of SARS-CoV-2 in aerosol and on surfaces

Extracorporeal membrane oxygenation shows benefit for patients with COVID-19 related severe acute respiratory distress syndrome.

#VisualAbstract: Low dose edoxaban prevents stroke in elderly patients with atrial fibrillation

#VisualAbstract: Increased proportion of out of hospital cardiac arrests at start at COVID-19

Use of legal performance enhancing substances increases risk of future anabolic steroid use

Association of the amount and pattern of physical activity with arterial stiffness: The Maastricht Study

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Childhood maltreatment may cause mental health problems
  • #VisualAbstract: Hydrochlorothiazide does not impact risk of kidney-stone recurrence
  • Metformin use may decrease risk of osteoarthritis development
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options